Does USTEKINUMAB Cause Osteomyelitis? 132 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 132 reports of Osteomyelitis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.2% of all adverse event reports for USTEKINUMAB.
132
Reports of Osteomyelitis with USTEKINUMAB
0.2%
of all USTEKINUMAB reports
4
Deaths
80
Hospitalizations
How Dangerous Is Osteomyelitis From USTEKINUMAB?
Of the 132 reports, 4 (3.0%) resulted in death, 80 (60.6%) required hospitalization, and 2 (1.5%) were considered life-threatening.
Is Osteomyelitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 132 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Osteomyelitis?
CANAGLIFLOZIN (2,146)
DENOSUMAB (701)
METHOTREXATE (673)
ADALIMUMAB (636)
ETANERCEPT (488)
ZOLEDRONIC ACID (419)
TOCILIZUMAB (400)
RITUXIMAB (360)
PREDNISONE (350)
LEFLUNOMIDE (332)
Which USTEKINUMAB Alternatives Have Lower Osteomyelitis Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE